Roselabs Finance
ROSELABSFINANCELTD NSE
Roselabs Finance
Financial ServicesNSE: ROSELABSFINANCELTD BSE: ROSELABS Other Financial Services
Key Fundamentals
MicrocapOther Financial ServicesFinancial ServicesMarket Cap
₹22.97 Cr
Volatility
Moderate
P/E Ratio
-74.8
EBITDA
₹-0.20 Cr
Return on Equity
6.1%
Debt to Equity
0
Book Value
₹-5.03
EPS
₹0
52W High
₹34.36
52W Low
₹17.86
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Weaknesses
1- Company has low interest coverage ratio.
Growth Rate
Revenue Growth
71.43% higher than
3Y
Net Income Growth
0% lower than
3Y
Cash Flow Change
37.5% higher than
3Y
ROE
-1.13% lower than
3Y
ROCE
250% lower than
3Y
EBITDA Margin (Avg.)
-59.23% lower than
3Y
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 1.14 | 0 | 0 | 0 | 0.71 | 0 | 0 | 1.21 | 0 | 0 |
| Expenses | 0.04 | 0.05 | 0.04 | 1.17 | 0.04 | 0.1 | 0.11 | 0.76 | 0.05 | 0.06 | 1.25 | 0.05 | 0.05 |
| Operating Profit | -0.04 | -0.05 | -0.04 | -0.03 | -0.04 | -0.1 | -0.11 | -0.05 | -0.05 | -0.06 | -0.04 | -0.05 | -0.05 |
| OPM % | — | — | — | -2.63% | — | — | — | -7.04% | — | — | -3.31% | — | — |
| Other Income | 0 | 0 | 0.01 | 0.03 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | -0.04 | -0.05 | -0.03 | 0 | -0.04 | -0.09 | -0.11 | -0.05 | -0.05 | -0.06 | -0.04 | -0.05 | -0.05 |
| Tax % | 0% | 0% | 0% | — | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 220% | 0% |
| Net Profit | -0.04 | -0.05 | -0.03 | 0 | -0.04 | -0.09 | -0.11 | -0.05 | -0.05 | -0.06 | -0.04 | -0.16 | -0.05 |
| EPS in Rs | -0.04 | -0.05 | -0.03 | 0 | -0.04 | -0.09 | -0.11 | -0.05 | -0.05 | -0.06 | -0.04 | -0.16 | -0.05 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 13.55 | 8.2 | 2.38 | 3.03 | 0 | 0 | 0.16 | 0 | 0 | 1.14 | 0.71 | 1.21 | 1.21 |
| Expenses | 9.59 | 7.87 | 1.87 | 2.83 | 0.29 | 0.14 | 0.16 | 0.44 | 0.69 | 1.31 | 1.02 | 1.41 | 1.41 |
| Operating Profit | 3.96 | 0.33 | 0.51 | 0.2 | -0.29 | -0.14 | 0 | -0.44 | -0.69 | -0.17 | -0.31 | -0.2 | -0.2 |
| OPM % | 29.23% | 4.02% | 21.43% | 6.6% | — | — | 0% | — | — | -14.91% | -43.66% | -16.53% | -16.53% |
| Other Income | 0.01 | 0.01 | 0 | 0.79 | 0.02 | 0 | -2.75 | 0 | 2.75 | 0.04 | 0.02 | 0 | 0 |
| Interest | 3.46 | 2.75 | 1.94 | 1.65 | 0.15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | 0.49 | -2.41 | -1.43 | -0.66 | -0.42 | -0.14 | -2.75 | -0.44 | 2.06 | -0.13 | -0.29 | -0.2 | -0.2 |
| Tax % | 0% | -0.41% | 0% | -33.33% | -7.14% | 0% | -6.18% | 0% | 2.43% | 0% | 0% | 55% | — |
| Net Profit | 0.49 | -2.4 | -1.43 | -0.43 | -0.39 | -0.14 | -2.57 | -0.44 | 2.02 | -0.13 | -0.29 | -0.31 | -0.31 |
| EPS in Rs | 0.49 | -2.4 | -1.43 | -0.43 | -0.39 | -0.14 | -2.57 | -0.44 | 2.02 | -0.13 | -0.29 | -0.31 | -0.31 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | -8.98 | -11.38 | -12.81 | -12.79 | -13.18 | -13.31 | -15.88 | -16.32 | -14.3 | -14.44 | -14.73 | -15.03 |
| Borrowings | 25.26 | 20.47 | 28.54 | 7.38 | 4.08 | 4.49 | 4.57 | 4.93 | 4.33 | 4.57 | 4.93 | 5.07 |
| Other Liabilities | 4.58 | 4.11 | 3.42 | 2.54 | 0.32 | 0.01 | 1.51 | 1.58 | 0.08 | 1.39 | 0.03 | 0.02 |
| Total Liabilities | 30.86 | 23.2 | 29.15 | 7.13 | 1.22 | 1.19 | 0.2 | 0.19 | 0.11 | 1.52 | 0.23 | 0.06 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 30.76 | 23.2 | 29.15 | 7.13 | 1.22 | 1.19 | 0.2 | 0.19 | 0.11 | 1.52 | 0.23 | 0.06 |
| Total Assets | 30.86 | 23.2 | 29.15 | 7.13 | 1.22 | 1.19 | 0.2 | 0.19 | 0.11 | 1.52 | 0.23 | 0.06 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | -1.74 | 7.14 | -5.66 | 23.11 | -0.5 | -0.42 | -0.2 | -0.38 | 0.58 | -0.18 | -0.32 | -0.2 |
| Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0.16 | 0 | 0 | 0 | 0 | 0 |
| Financing | 1.93 | -6.77 | 5.99 | -23.65 | 0.05 | 0.42 | 0.07 | 0.36 | -0.6 | 0.24 | 0.37 | 0.14 |
| Net Cash Flow | 0.19 | 0.37 | 0.33 | -0.54 | -0.45 | 0 | 0.04 | -0.02 | -0.02 | 0.06 | 0.05 | -0.06 |
| Free Cash Flow | -1.74 | 7.14 | -5.66 | 23.11 | -0.5 | -0.42 | -0.2 | -0.38 | 0.58 | -0.18 | -0.32 | -0.2 |
| CFO/OP | -41 | 2,152 | -1,104 | 11,595 | 83 | 300 | — | 86 | -84 | 106 | 103 | 100 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 323 | 534 | 1,840 | 0 | — | — | 0 | — | — | 429 | 0 | 0 |
| Inventory Days | 287 | 258 | 636 | 0 | — | — | — | — | — | — | — | — |
| Days Payable | 30.59 | 35.61 | 66.59 | — | — | — | — | — | — | — | — | — |
| Cash Conversion Cycle | 579 | 757 | 2,410 | 0 | — | — | 0 | — | — | 429 | 0 | 0 |
| Working Capital Days | -216 | -314 | -2,471 | -864 | — | — | -3,468 | — | — | -16.01 | -10.28 | -3.02 |
| ROCE % | 16.33% | 1.5% | 2.28% | 6.53% | -9.84% | -13.46% | — | — | — | -162.5% | -175.76% | -166.67% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Roselabs Finance insights
58 extracted metrics + investor summaries across FY11–FY26.
Documents
1
Announcement under Regulation 30 (LODR)-Newspaper Publication
17 Apr - Newspaper publication of the audited financial results for the quarter and financial year ended March 31, 2026 17 Apr - Newspaper publication of the audited financial results for the quarter and financial year ended March 31, 2026
2
Board Meeting Outcome for Audited Financial Results For The Quarter And Financial Year Ended March 31, 2026
16 Apr - Board approved audited Q4 and FY26 results; auditor issued unmodified opinion. 16 Apr - Board approved audited Q4 and FY26 results; auditor issued unmodified opinion.
4
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
16 Apr - Board appointed Walker Chandiok as statutory auditor for FY2026-27 to FY2031-32; Shravan A. Gupta as secretarial auditor for FY2026-27. 16 Apr - Board appointed Walker Chandiok as statutory auditor for FY2026-27 to FY2031-32; Shravan A. Gupta as secretarial auditor for FY2026-27.
5
Appointment Of Secretarial Auditor
16 Apr - Board approved Walker Chandiok as statutory auditor and Shravan A. Gupta & Associates as secretarial auditor. 16 Apr - Board approved Walker Chandiok as statutory auditor and Shravan A. Gupta & Associates as secretarial auditor.
Frequently Asked Questions about Roselabs Finance
What does Roselabs Finance Ltd do?
Incorporated in 1995, Roselabs Finance Ltd is in the business of real estate development[1]
Where is Roselabs Finance Ltd (531324) listed?
Roselabs Finance Ltd trades as ROSELABSFINANCELTD on the NSE and under code ROSELABS on the BSE.
Which sector does Roselabs Finance Ltd belong to?
Roselabs Finance Ltd is classified under the Financial Services sector, in the Other Financial Services industry.
What is the market capitalisation of Roselabs Finance Ltd?
Roselabs Finance Ltd has a market capitalisation of ₹22.97 Cr, which places it in the Small Cap band.
What is the PE ratio of Roselabs Finance Ltd?
Roselabs Finance Ltd trades at a PE ratio of -74.80, on earnings per share of ₹0, against a book value of ₹-5.03 per share.
What is the 52-week high and low of Roselabs Finance Ltd?
Over the last 52 weeks Roselabs Finance Ltd has traded between ₹17.86 and ₹34.36.
What is the Return on Equity (ROE) of Roselabs Finance Ltd?
Roselabs Finance Ltd reported a return on equity of 6.10%. Its debt-to-equity ratio is 0.00.
Company Information
Incorporated in 1995, Roselabs Finance Ltd is in the business of real estate development[1]
Website roselabsfinancelimited.in
Face Value ₹ 10
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/531324.md for Roselabs Finance Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.